Natural withanolides in the treatment of chronic diseases

Keyphrases

• Activator protein-1 (AP-1) 20%
• Adaptogen 20%
• Adverse Effects 20%
• Anti-inflammatory Properties 20%
• Antitussive 20%
• Anxiolytic 20%
• Arthritis 20%
• Asian Countries 20%
• Autoimmune 20%
• Biologic Activity 20%
• Chronic Disease 100%
• Clinical Application 20%
• Complex Disease 20%
• Disease Process 20%
• Diuretics 20%
• Ergostane 20%
• Heat Shock Protein 90 (Hsp90) 20%
• Hypoxia-inducible factor-1α (HIF-1α) 20%
• Immunomodulatory 20%
• Inflammation 20%
• Inflammatory Pathways 40%
• JAK-STAT 20%
• Medical Systems 20%
• Medical Use 20%
• Multiple Mechanisms of Action 20%
• Naturally Derived Compounds 20%
• Neurobehavior 20%
• Neurodegenerative 20%
• NF-B 20%
• Novel Therapeutics 20%
• Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) 20%
• Pharmacologic 20%
• Pharmacological Properties 20%
• Sedative 20%
• Steroidal Lactones 20%
• Withaferin A 20%
• Withania Somnifera 20%
• Withanolides 100%

Medicine and Dentistry

• Adaptogenic 20%
• Adverse Event 20%
• Anti-Inflammatory Drug 40%
• Antitussive Agent 20%
• Arthritis 20%
• Chronic Disease 100%
• Disease Process 20%
• Diuretic Agent 20%
• Lactone 20%
• Malignant Neoplasm 20%
• Peroxisome Proliferator Activated Receptor 20%
• Sedative Agent 20%
• Skeleton 20%
• Transcription Factor Nrf2 20%
• Withaferin A 20%
• Withania somnifera 20%
• Withanolide 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Adaptogenic 20%
• Adverse Event 20%
• Anti-Inflammatory Drug 40%
• Antitussive Agent 20%
• Arthritis 20%
• Chronic Disease 100%
• Disease 20%
• Diuretic Agent 20%
• Inflammation 20%
• Lactone 20%
• Malignant Neoplasm 20%
• Peroxisome Proliferator Activated Receptor 20%
• Transcription Factor Nrf2 20%
• Withaferin A 20%
• Withania somnifera 20%
• Withanolide 100%